Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 13.551.571.551.401.55

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 13.55 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202513.55
Mar20241.57
Mar20231.55
Mar20221.40
Mar20211.55

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 13.55
763.06
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4
-9.68
Mar2021 1.55 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹32,692.9 Cr 2.4% 2.3% 26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,667.0 Cr 1.4% -4.5% 6.5% Stock Analytics
DIVIS LABORATORIES ₹176,805.0 Cr 0.1% -2.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,554.0 Cr -2.7% 1.2% 39.3% Stock Analytics
CIPLA ₹109,120.0 Cr -2.3% -5.3% -9.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,920.0 Cr -0.5% -4.7% -5.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

2.4%

2.3%

26.9%

SENSEX

4.3%

2.6%

-6.4%


You may also like the below Video Courses